In this web seminar, HESI CT-TRACS* committee speakers will provide an overview of technologies currently available for use in patients, how these are relevant to evaluate safety and efficacy aspects of cellular therapies, and the importance of collaboration to address challenges and needs facing the translation of cell therapies into the clinic. The presentation will be followed by a Question and Answer Session.
*The Health and Environmental Sciences Institute (HESI) / Cell Therapy – TRAcking, Circulation, & Safety (CT-TRACS) committee provides a neutral platform for cell therapy developers, researchers, regulators, imaging specialists, and other stakeholders to interact, discuss current challenges and identify best practices to improve confidence in the safety and efficacy of these therapies.
- HESI CT-TRACS: a Collaborative Effort to Address Collective Challenges & Needs | Bill Shingleton, BSc, PhD
- Tracking Cells after Administration: Imaging Modalities and Probes | Brooke Helfer, PhD
- The Need for Collaboration Across Stakeholders to Address the Challenges Facing the Translation of Cell Therapies into the Clinic | David Morrow, PhD, MBA
- Aligning Academic Cell Therapy Manufacturing Facility Capability with FDA Requirements: Can We Increase Output as Demand Ramps Up? | Linda Kelley, PhD
- Design, Construction and Commissioning of an Academic Cellular Manufacturing Facility | Amittha Wickrema, PhD